title: Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.
authors.affiliation: Hamilton Glaucoma Center, University of California, San Diego, La Jolla, California 92093-0946, USA. weinreb@eyecenter.ucsd.edu
authors.forename: Robert N
authors.initials: RN
authors.lastname: Weinreb
authors.forename: Paul L
authors.initials: PL
authors.lastname: Kaufman
mesh_terms: D035843:Biomedical Research; D002986:Clinical Trials as Topic / Q000639:trends*; D003941:Diagnostic Techniques, Ophthalmological / Q000295:instrumentation / Q000639:trends*; D018450:Disease Progression; D023381:Endpoint Determination / Q000639:trends; D005901:Glaucoma / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007429:Intraocular Pressure; D054554:National Eye Institute (U.S.); D009885:Ophthalmology / Q000639:trends*; D012107:Research Design / Q000639:trends*; D014481:United States; D014486:United States Food and Drug Administration; D014792:Visual Acuity / Q000502:physiology*